We have nothing to declare but our Genius.
We have nothing to declare but our Genius.
Our new Genius range offers superb technical performance in the lab and comes with our 'world class' after sales service as standard.
The 'NM32LA' Nitrogen Generator has been specifically designed to operate LCMS manufactured by Waters Corporation, Thermo Fisher Scientific, Agilent Technologies, Shimadzu, Bruker and similar, producing the required flow rates, purities and pressures to cater for the requirements of this application.
Extensively tested under supervision of Peak and LCMS Manufacturers, the 'NM32LA' has been approved to supply Nitrogen to their LCMS Applications.
The 'NM32LA' generates Nitrogen through the application of 'Membrane Technology'. Nitrogen membranes separate gases by the principle of selective permeation across the nitrogen membrane wall."Fast" gases permeate through the nitrogen membrane wall more readily than "slow" gases, thus separating the original gas mixture into 2 streams. The purity of the desired streams can be adjusted depending on operating conditions.
Internal air compressors further make the 'NM32LA' a stand-alone, self- sufficient Nitrogen Generator, independent from external air sources.
To learn more about this product please ref="http://www.peakscientific.com/product/NM32LA">click here.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.